Medical News

RSS

USPTO issues patent number to Vermillion's biomarkers for detecting ovarian cancer

Vermillion, Inc., a molecular diagnostics company, today announced that the U.S. Patent Office (USPTO) has issued patent number 7,605,003 titled "Use of biomarkers for detecting ovarian cancer" to the Company for the discovery of biomarkers for ovarian cancer.

12 Nov 2009

Second-quarter fiscal 2010 results announced by Cyanotech

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the second quarter and first six months of fiscal 2010, ended September 30, 2009.

12 Nov 2009

Arrayit Diagnostics develops diagnostic tests for early cancer detection

Arrayit Corporation announced today that the company's majority owned subsidiary, Arrayit Diagnostics, Inc., will launch the most intensive marketing campaign in the company's thirteen-year history. The company is currently developing several diagnostic tests that will provide early detection for cancers, neurodegenerative diseases and other disease states.

12 Nov 2009

Financial results for third-quarter 2009 announced by Spectral Diagnostics

Spectral Diagnostics Inc., today announced its financial results for the third quarter ended September 30, 2009.

12 Nov 2009

MAP Pharmaceuticals to sell up to $60 million of its registered common stock to Azimuth Opportunity

MAP Pharmaceuticals, Inc. today announced that it has secured a committed equity financing facility under which it may sell up to $60 million of its registered common stock to Azimuth Opportunity Ltd. MAP Pharmaceuticals is not obligated to utilize any of the $60 million facility, which has a term of 24 months.

12 Nov 2009

Meridian Bioscience announces fiscal 2009 fourth-quarter and full-year financial results

Net sales for the fourth quarter of fiscal 2009 were $42,461,000 as compared to $36,475,000 for the same period of the prior fiscal year, an increase of 16%. Net earnings for the fourth quarter of fiscal 2009 were $8,930,000, or $ 0.22 per diluted share, up 16% over the fourth quarter of fiscal 2008.

12 Nov 2009

Review of Mersana Therapeutics's lead compound, XMT-1001 to be published

Mersana Therapeutics, a platform-based cancer therapeutics company, announced today that a review of the Company's lead compound, XMT-1001, will appear in the November 12, 2009 special issue of Advanced Drug Delivery Reviews on Polymer Therapeutics: Clinical Applications and Challenges for Development.

12 Nov 2009

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

Bradmer Pharmaceuticals Inc. today announced its 2009 third quarter financial results.

12 Nov 2009

Financial results for the third quarter announced by A.D.A.M.

A.D.A.M., Inc., a leading provider of health information and benefit technology solutions, today announced its financial results for the third quarter ended September 30, 2009.

12 Nov 2009

Medical Facilities announces financial results for the third quarter of 2009

Medical Facilities Corporation, today reported its financial results for the three and nine-month periods ended September 30, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.

12 Nov 2009

"Doctors Speak Out" series to discuss today's health issues

How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today’s most pressing health issues.

12 Nov 2009

LAB Research announces financial results for the third quarter of 2009

LAB Research Inc., a global Canadian-based non-clinical contract research organization, today announced its 2009 third quarter financial results.

12 Nov 2009

First Edition: October 12, 2009

Today's headlines continue to focus on certain aspects of pending health overhaul measures, while also noting that the timeline for Capitol Hill action is now stretching closer to the Christmas holiday.

12 Nov 2009

Jonathan Richman to present at FDA public hearing on promoting medical devices using the Internet

Bridge Worldwide announced today that Jonathan Richman, Director of Strategic Planning, will present at the public hearing on "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools," to be held on November 12 and 13, 2009, from 8 a.m. to 5 p.m., at the National Transportation Safety Board Conference Center in Washington, D.C. Richman is scheduled to speak on Friday, November 13, at 11:40 a.m. and 2:40 p.m. for 10 minutes per time slot. To listen to a free, live webcast of the hearing, go to: www.capitolconnection.net/capcon/fda/111209/FDAlive.htm.

12 Nov 2009

Gallup-Healthways monthly U.S. well-being report released

Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for October 2009.

12 Nov 2009

D-Link to showcase its Green networking hardware at the HealthAchieve2009 conference

D-Link has been selected to showcase its environmentally responsible Green networking hardware as part of the Venture Green program in this year's HealthAchieve2009 conference and exhibition on Nov. 16-17 at the Metro Toronto Convention Centre.

12 Nov 2009

Posey StaySafe Bed for European markets

The Posey Company, a leader in the design and manufacture of innovative and reliable patient safety solutions, today officially announced the availability of the Posey StaySafe(TM) Bed, Model 8080, for European markets. The bed has been designed for sale in Holland, France, and Germany; sales to additional European country markets will follow.

12 Nov 2009

Baby Boomers seek alternatives for prescription only treatments for menopause symptoms

As an increasing number of women from the Baby Boomer generation approach or have already reached menopause, more are seeking alternatives to prescription only treatments for menopause symptoms, and more are discovering Femnene and its line of feminine products designed specifically for a woman during and after the change of life.

12 Nov 2009

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers.

12 Nov 2009

Oxytocin hormone affects behaviors, finds new study

A new study carried out at the University of Haifa has found that oxytocin, also known as the "love hormone", which affects behaviors such as trust, empathy and generosity, also affects opposite behaviors, such as jealousy and gloating.

12 Nov 2009